Your Lost Pharmaceutical Revenue: Uncovering the Costly “Unknown”

The battle to exceed pharmaceutical annual projections is complex and challenging, and many pharmaceutical companies in 1H 2025 are missing goals. Pressures mount as we deal with government pricing reductions, PBM discounts driving access, and consumerism driven by tolerance of skyrocketing out-of-pocket costs. 

The historical ways to solve revenue goal achievement aren’t working, and brand leads who double down on these historical tactics are finding themselves and their teams in a tenuous position.

In a rip current, swimmers are instructed not to struggle toward shore but to swim parallel to it. Thus, they get out of the deadly stream and head for safe land in manageable waters.

A quick and easy revenue fix for pharmaceutical brand leads is to capture lost prescriptions that can be as high as 30% to 50% of sales. This lost revenue will vary by brand, with actual losses determined by price, access, complexity, and stakeholder determination to dispense.

There are two keys to the “Unknown”: 

ACTUAL lost Rx—Current models of tracking lost sales woefully underreport lost prescriptions. And unless new data sets are engaged—sets that can see all prescriptions and reliably bring lost scripts into view—revenue will continue to be lost.

What can be done? By capturing prescriptions that have been lost along the prescription journey, we are able to do what no one else is capable of doing. We can identify the problem and fix it for many prescriptions—both new and old.

Through our proprietary approach, we are able to access unique data. In near real time. By having this type of access and understanding how to use it, we are able to smooth the entire Rx journey, affecting and improving Rx hygiene, rejection notification, support, and even adherence.

A conservative estimate of our impact has been seen by brands at a rate of over 10% improvement within the first few weeks of deployment. For a large brand, our utility can mean more than $100M recovered revenue per year, sustainably. 

Brand and corporate leads who are not addressing this lost revenue are leaving money on the table and frustrating their providers, who cannot deliver intended care. The implications are many if this growing challenge of fulfilling prescriptions continues to be unaddressed.

Today’s evolving pharmaceutical market requires evolution in supporting the prescription journey. Quick, easy, measurable, and confident wins that capture significant lost revenue should become part of any brand or corporation that is working to achieve or exceed performance goals.

Contact Aventria Health Group if you’d like to learn more about our Notification Tool and how it can be leveraged for your brand(s). 

To learn more about how we can help you, please reach out to:

Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer, and pharmacy communications, at dwdierk@aventriahealth.com.

Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities